Equifax (NYSE:EFX - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 7.250-7.650 for the period, compared to the consensus EPS estimate of 7.480. The company issued revenue guidance of $5.9 billion-$6.0 billion, compared to the consensus revenue estimate of $6.0 billion. Equifax also updated its Q2 2025 guidance to 1.850-1.950 EPS.
Wall Street Analysts Forecast Growth
EFX has been the topic of a number of recent research reports. Barclays restated an "equal weight" rating and issued a $260.00 target price (down from $325.00) on shares of Equifax in a report on Friday, April 4th. Gordon Haskett upgraded shares of Equifax to a "strong-buy" rating in a research note on Tuesday, February 18th. Bank of America assumed coverage on Equifax in a research note on Thursday, April 10th. They set a "buy" rating and a $280.00 price target for the company. UBS Group lowered their target price on shares of Equifax from $335.00 to $310.00 and set a "buy" rating on the stock in a research note on Friday, February 7th. Finally, Argus downgraded Equifax from a "buy" rating to a "hold" rating in a research report on Tuesday, February 11th. Five equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $292.00.
View Our Latest Analysis on Equifax
Equifax Trading Down 0.2 %
NYSE:EFX traded down $0.58 during trading hours on Friday, hitting $256.62. The stock had a trading volume of 1,118,422 shares, compared to its average volume of 965,085. The business's 50 day moving average is $236.34 and its 200-day moving average is $253.94. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.88 and a current ratio of 0.75. The company has a market cap of $32.03 billion, a price-to-earnings ratio of 53.13, a P/E/G ratio of 2.79 and a beta of 1.65. Equifax has a one year low of $199.98 and a one year high of $309.63.
Equifax (NYSE:EFX - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The credit services provider reported $1.53 earnings per share for the quarter, beating analysts' consensus estimates of $1.45 by $0.08. The firm had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.41 billion. Equifax had a net margin of 10.63% and a return on equity of 19.13%. Sell-side analysts anticipate that Equifax will post 7.58 EPS for the current fiscal year.
Equifax Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be paid a dividend of $0.50 per share. This is a boost from Equifax's previous quarterly dividend of $0.39. This represents a $2.00 annualized dividend and a dividend yield of 0.78%. The ex-dividend date of this dividend is Friday, May 23rd. Equifax's dividend payout ratio (DPR) is currently 32.30%.
Institutional Investors Weigh In On Equifax
A hedge fund recently raised its stake in Equifax stock. Brighton Jones LLC raised its stake in Equifax Inc. (NYSE:EFX - Free Report) by 49.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,638 shares of the credit services provider's stock after purchasing an additional 1,200 shares during the quarter. Brighton Jones LLC's holdings in Equifax were worth $927,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 96.20% of the company's stock.
Equifax Company Profile
(
Get Free Report)
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Recommended Stories

Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.